TABLE 3.

Calibration analysis for each score at 28-day and 90-day.

Variates	28-day				90-day
	H-L test		Calibration plot		H-L test		Calibration plot
	χ2	p	Intercept	Slope	χ2	p	Intercept	Slope
Total HBV-ACLF patients (n = 919)
COSSH-ACLF IIs	10.266	0.247	–0.008	1.034	8.403	0.395	–0.020	1.053
COSSH-ACLFs	18.841	0.016	–0.018	1.082	21.148	0.007	–0.025	1.068
CLIF-C ACLFs	3.332	0.912	–0.009	1.040	4.577	0.802	–0.013	1.036
MELDs	17.386	0.026	–0.030	1.135	32.330	<0.001	–0.043	1.118
MELD-Nas	18.717	0.016	–0.029	1.134	18.132	0.020	–0.026	1.071
TPPMs	23.880	0.002	0.050	0.804	14.567	0.068	0.049	0.882
All cirrhotic patients (n = 675)
COSSH-ACLF IIs	10.448	0.235	–0.008	1.034	6.999	0.537	–0.014	1.034
COSSH-ACLFs	12.521	0.129	–0.026	1.108	15.544	0.049	–0.030	1.074
CLIF-C ACLFs	7.967	0.437	–0.007	1.027	3.474	0.901	–0.016	1.037
MELDs	19.416	0.013	–0.035	1.143	15.484	0.001	–0.046	1.111
MELD-Nas	10.935	0.205	–0.021	1.087	14.827	0.063	–0.029	1.072
TPPMs	30.528	<0.001	0.116	0.609	13.580	0.093	0.076	0.837
All non-cirrhotic patients (n = 244)
COSSH-ACLF IIs	10.954	0.204	–0.010	1.064	7.418	0.492	–0.022	1.084
COSSH-ACLFs	9.615	0.293	–0.012	1.082	16.716	0.033	–0.020	1.075
CLIF-C ACLFs	11.343	0.183	–0.001	1.006	9.419	0.308	–0.006	1.018
MELDs	7.269	0.508	–0.013	1.079	12.435	0.133	–0.036	1.149
MELD-Nas	12.191	0.143	0.011	0.919	4.585	0.801	–0.029	1.113
TPPMs	6.076	0.639	0.014	0.919	10.372	0.240	0.068	0.755

COSSH-ACLF II score, Chinese Group on the Study of Severe Hepatitis B-ACLF II score; COSSH-ACLFs, Chinese Group on the Study of Severe Hepatitis B-ACLF score; CLIF-C ACLFs, CLIF-Consortium Acute-on-Chronic Liver Failure score; TPPMs, Tongji Prognostic Predictor Model score; MELDs, Model for End-Stage Liver Disease score; MELD-Nas, MELD-Sodium score.